Related Experiment Video
Updated: Jan 11, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
CTLA4-Ig sustains osteogenic potential and inhibits osteoclastogenesis in Staphylococcus aureus osteomyelitis
Rongjie Lin1, Yiqing Huang1, Zhenbin Chen1
1Department of Orthopedic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Abstract:
Osteomyelitis (OM) is a severe bone-destructive disease characterized by infection and inflammation. Transcriptomic analysis of datasets GSE18043 and GSE30119 identified CTLA4 as a key regulator associated with immune modulation and osteogenic differentiation. Subsequent bioinformatic and immune infiltration analyses revealed that CTLA4 expression correlated with increased anti-inflammatory macrophage infiltration and activation of the Wnt/β-catenin signaling pathway of osteoblasts. Functionally, CTLA4-Ig promoted osteogenic differentiation, enhanced matrix mineralization, and upregulated osteogenic markers in MC3T3-E1 cells, while concurrently inhibiting osteoclast formation and bone resorption activity. In a Staphylococcus aureus-induced rat OM model, histological and immunohistochemical analyses further confirmed enhanced osteoblast activity and reduced osteoclast presence in the CTLA4-Ig treated group. CTLA4-Ig administration preserved bone structural integrity by modulating the inflammatory microenvironment, characterized by reduced expression of pro-inflammatory cytokines, increased levels of anti-inflammatory cytokines, enhanced osteogenic regeneration, and a reduction in bacterial burden. Collectively, these findings established CTLA4-Ig as a dual-action modulator that promoted bone regeneration while inhibiting bone destruction, offering a promising therapeutic strategy for OM.
Insights
Cytotoxic T-lymphocyte-associated protein 4 (CTLA4)-Ig shows promise for treating osteomyelitis (OM). It promotes bone regeneration and reduces bone destruction by modulating the immune microenvironment, offering a dual therapeutic approach.
Area of Science:
- Immunology
- Orthopedics
- Regenerative Medicine
Background:
- Osteomyelitis (OM) is a severe bone disease involving infection and inflammation.
- Identifying key regulators for immune modulation and bone regeneration is crucial for OM treatment.
Purpose of the Study:
- To investigate the role of CTLA4 in osteomyelitis.
- To evaluate the therapeutic potential of CTLA4-Ig in promoting bone regeneration and inhibiting bone destruction in OM.
Main Methods:
- Transcriptomic analysis of OM datasets (GSE18043, GSE30119).
- Bioinformatic and immune infiltration analyses.
- In vitro studies using MC3T3-E1 cells.
- In vivo studies using a Staphylococcus aureus-induced rat OM model.
Main Results:
- CTLA4 expression correlated with anti-inflammatory macrophage infiltration and Wnt/β-catenin pathway activation.
- CTLA4-Ig promoted osteogenic differentiation and matrix mineralization in vitro.
- CTLA4-Ig inhibited osteoclast formation and bone resorption in vitro.
- CTLA4-Ig treatment in vivo enhanced osteoblast activity, reduced osteoclast presence, and improved bone structural integrity.
- CTLA4-Ig modulated the inflammatory microenvironment, reducing pro-inflammatory cytokines and bacterial burden.
Conclusions:
- CTLA4 is a key regulator in osteomyelitis, influencing immune modulation and osteogenic differentiation.
- CTLA4-Ig demonstrates dual action, promoting bone regeneration while inhibiting bone destruction.
- CTLA4-Ig represents a promising therapeutic strategy for osteomyelitis by modulating the inflammatory microenvironment and enhancing bone repair.
Related Concept Videos
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...

